Factory Direct Asthma Drugs 99% Pranlukast CAS 103177-37-3 for Antiasthmatic
GMP ISO 1 Inquiries
103177-37-3
Pharmaceutical Grade
0%
Foil Bag, Box, Drum
2022-12-31
Minoxidil,Paracetamol,Diclofenac sodium,fenbendazole,Ivermectin
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
Basic INFORMATION
Name: Pranlukast
CAS Number: 103177-37-3
Formula: C27H23N5O4
Molecular Weight: 481.50
EINECS: 201-616-4
Color: White
Form :Powder
Melting point: 236-238°C
Storage condition: Store at +4°C
Pranlukast is a common respiratory drug, it belongs to asthma drugs , it is the cysteinyl leukotrienes (LTs) receptor antagonist and it can bind to LTC4, LTD4, LTE4 receptors selectively to antagonize their effect . Roles and application are similar to zafirlukast. It is clinically used for the prevention of bronchial asthma. Oral 225mg once, 2 times one day, morning and evening after meal. After taking ,there may be gastrointestinal reactions,or there may be nausea, vomiting, abdominal pain, diarrhea or constipation, sometimes , fever, rash, pruritus and liver function abnormalities such as serum aminotransferase or bilirubin increase are visible . Pregnant women should use with caution , the elderly should take appropriate reductions. This product can not alleviate the onset of asthma.
1, zafirlukast: it is effective for mild to moderate asthma ,it can cause improvement in dose-dependent lung function, and reduce the amount of β agonists. Absorption of the product is affected by food, it should not be taken together with food. Oral each 20mg, 2 times/d.
2, montelukast: it is valid for intermittent or persistent asthma in adults and children. This product is approved by the FDA for the treatment of children aged 6 to 12. Absorption of the product is not affected by food, it can be taken with food . Oral each 10mg, once/d.
3, pranlukast: it is used for mild to moderate asthma, pranlukast can increase patients maximum expiratory flow,and improve asthma symptoms, it can be used as a daily treatment of chronic asthma. Each oral 450mg, 2 times/d.
CertificatesBasic Info-
Product Name:
Pranlukast
Other Name:Benzamide,N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-;Benzamide,N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-;N-[4-Oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide;RS 411;ONO 1078;Pranlukast;ONO-RS 411;SB 205312;8-[4-(4-Phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;Onon;CCN 00401;Azlaire;4-Oxo-8-[4-(4-phenylbutoxy)benzoylamino]-2-(tetrazol-5-yl)-4H-1-benzopyran
CAS No.:103177-37-3
Molecular Formula:C27H23N5O4
InChIKeys:InChIKey=NBQKINXMPLXUET-UHFFFAOYSA-N
Molecular Weight:481.5
Exact Mass:481.50
EC Number:201-616-4
UNII:TB8Z891092
DSSTox ID:DTXSID9021180|DTXSID3043782
ATC Code:R - Respiratory system
Categories:
Characteristics-
PSA:
119
XLogP3:4.2
Appearance:off-white solid
Density:1.374±0.06 g/cm3(Predicted)
Melting Point:236-238°C
Refractive Index:1.681
Storage Conditions:Store at +4°C
Toxicity:LD50 in male mice (mg/kg): >1000 i.v. (Toda)
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Eye irritation, Category 2
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H319 Causes serious eye irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Minoxidil,Paracetamol,Diclofenac sodium,fenbendazole,Ivermectin
-
Location:
I-City unit 3, South of Tangyan Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2015
-
Certifications:
HACCP,Halal,GMP,ISO
"> -
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Switzerland
Antiasthmatic Drugs Pranlukast Powder CAS 103177-37-3 Pranlukast
10000 MT Aug 28, 2023 Post an enquiry for this product